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Abstract 
Cheese is a rich source of essential nutrients; in particular, proteins, fat, vitamins and 
minerals. In addition to their nutritional role, cheese components are also able to exert 
important health benefits, with calcium, fatty acids and bioactive peptides being the main 
players. This chapter presents an updated revision on the health effects of cheese components 
focusing on the most studied bioactive peptides activities. They are liberated during cheese 
ripening, where casein is hydrolyzed by proteases and peptidases from milk, rennet, starter 
culture, and secondary microbial flora. Some of the generated peptides can survive 
gastrointestinal digestion or serve as precursors from the final peptide form, responsible of a 
wide array of biological activities such as antihypertensive, antioxidant, antimicrobial or 
opioid.  
In the chapter, the degree of evidence reached for the bioactive components described, as 
well as the bioavailability studies performed in each case are also discussed. 
 
Keywords: cheese, bioactive peptides, cheese health effects, fat, proteins, vitamins, minerals, 
bioavailability 
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11.1. Introduction 
Cheese is a nutritious, versatile dairy food with a long history in the human diet. The 
high content of fat and protein in cheese makes it an energy-rich and nutritious food 
recommended for all ages. Nowadays, a wide variety of cheese types are available to meet 
specific consumer requirements and allow convenience use. Europe (EU 27) is the biggest 
producer of cheese, with an average production of 8,998 kt during the period 2010-2012 . 
Average per capita consumption of cheese in EU 27 has been reported to be 17.2 kg during 
the period 2010-2012. From the integrant countries, France, Iceland, Luxembourg, Germany, 
and Finland were the biggest consumers with more than 23.5 kg/capita during 2012 (Bulletin 
of the International Dairy Federation, 2013). 
Cheese is a rich source of essential nutrients; in particular, proteins, fat, vitamins and 
minerals. In addition to their nutritional role, cheese components have also revealed to 
potentially exert important health benefits (Walther et al., 2008). Calcium, present in large 
amounts in cheese, has been shown to have a positive effect on various disorders such as 
osteoporosis (Heaney, 2000) or dental caries (Kato et al., 2002). Besides calcium, some fatty 
acids present in cheese such as conjugated linoleic acid (CLA) have demonstrated to display 
anti-carcinogenic and anti-atherogenic properties (Lee et al., 2005; Battacharaya et al., 2006). 
Bioactive peptides are also present in cheese. They are produced during cheese ripening, 
where casein is broken down by proteases and peptidases from milk, rennet, starter culture, 
and secondary microbial flora. Some of the generated peptides can survive gastrointestinal 
digestion or serve as precursors from the final peptide form, responsible of a wide array of 
biological activities (López-Expósito et al., 2012).  
This chapter presents an updated revision on the health effects of cheese components 
focusing on the most studied bioactive peptides activities. The degree of evidence reached, as 
well as the bioavailability studies performed in each case will be discussed. 
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11.2. Effects of cheese fat on health 
The physical, organoleptic and nutritional properties that milk lipids impart to dairy 
products make them one of the most important components of milk. However, their high 
content of saturated fatty acids and cholesterol has been used by nutritionists as an argument 
to associate the consumption of these products with an increased incidence of obesity, 
metabolic disorders and cardiovascular diseases (CVD). Nevertheless, recent studies indicate 
that there are no demonstrated evidences to recommend the consumption of low-fat dairy 
foods in healthy people because of the biological activities demonstrated for several 
compounds present in milk fat (Fontecha et al., 2011).  
Conjugated linoleic acid (CLA) refers to a group of polyunsaturated fatty acids that 
exist as positional and stereo-isomers of conjugated dienoic octadecadienoate (C18:2). The 
fatty acid profile and the CLA content of cheese (Table 1) are influenced by environmental 
factors, farming practices and genetic and physiological aspects related to the animals 
(Collomb et al., 2006). Moreover, factors involved in cheesemaking process, such as heat 
treatment of milk and/or curd, addition of starter cultures and ripening have an important 
effect on CLA levels in cheese. It has been shown that certain lactic acid bacteria used in milk 
fermentation posses the ability to generate CLA (Prandini et al., 2007). Therefore, recent 
studies are focused on increasing the CLA content of cheese by supplementing the animal’s 
diet with vegetable oils (rich in polyunsaturated fatty acids, Nudda et al., 2014) and/or by 
adding dairy starters producers of CLA during cheese manufacture (de Lima Alves et al., 
2011). Rumenic acid, corresponding to the CLA isomer C18:2 cis 9, trans 11, is the most 
abundant isomer, accounting for around 80-90% of the total CLA (Parodi, 1999). A high 
number of in vitro studies and animal models have shown that it is responsible for the anti-
carcinogenic and anti-atherogenic properties attributed to CLA (Lee et al., 2005; Battacharaya 
et al., 2006). Besides rumenic acid, other CLA isomers have a positive impact on human 
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health. As an example, the C18:2 trans 10, cis 12, has been reported to promote weight loss, 
decreasing glucose levels and insulin resistance in obese men with the metabolic syndrome 
(Riserus et al., 2002), while isomer C18:2 trans 9, trans 11 acts inhibiting growing of human 
colon cancer cells (Coakley et al., 2006).  
Although a notable number of clinical studies have evaluated the biological properties 
of purified rumenic acid or CLA isomers mixtures on CVD risk factors (Wang et al., 2012), 
relatively little information from dietary intervention studies with CLA-enriched cheeses is 
available. Sofi et al. (2010) observed beneficial effects of consumption by healthy subjects of 
a sheep cheese naturally rich in rumenic acid on several atherosclerotic biomarkers, in 
comparison with a commercially available cheese. Pintus et al. (2013) reported an 
improvement of the lipid profile and reduction of endocannabinoid synthesis in the plasma of 
hypercholesterolemic subjects after consumption of sheep cheese naturally enriched in α-
linolenic, CLA and vaccenic acid. If these beneficial effects are confirmed by further studies, 
this will likely have important repercussion for human nutrition and food industry.  
Short-chain fatty acids, such as butyric acid (C4), caproic (C6) and medium-chain 
fatty acids, such as caprilic (C8) and capric acids (C10), represent 10-12% of total saturated 
fatty acids. Apart from its antimicrobial properties (Huang et al., 2011), the butyric acid, 
present in milk fat in concentrations ranged from to 2 to 5%, has been described as an 
anticarcinogenic agent inhibiting growth of a wide range of human cancer cell lines (Blank-
Porat et al., 2007). Furthermore, synergisms between butyric acid and other dietary 
compounds and common drugs in reducing cancer cell growth have also been shown (Parodi 
2006). However, no human studies have been conducted to confirm these effects after 
consumption of cheese.  
11.3. Minerals in cheese and their impact on health 
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The specific amount of minerals in cheese differs according to the manufacturing 
procedure of a cheese type. For example, the method of coagulation used and the acidity of 
the curd will have an effect on the salt concentration. Ripened cheeses constitute an abundant 
source of mineral compounds. Calcium, phosphorus, sodium and chloride will be in high 
amounts while elements such as zinc and potassium will be in at much lower concentration 
(Table 2). As shown in this Table, it is remarkable the higher daily value of calcium and 
phosphorus with regard to the rest of the minerals shown. Research has shown that an 
insufficient intake of calcium, in particular, raises the risk of obesity (Parikh and Yanovski 
2003), hyperlipidemia and insulin-resistance syndrome (Teegarden 2003; Zemel 2004). On 
the contrary, a diet rich in dairy calcium intake enhanced weight reduction in type 2 diabetic 
patients (Shahar et al., 2007).  
A considerably body of research has been published on the cariostatic effect of cheese 
(Kashket and DePaola 2002). Assays on human subjects have suggested a caries-protective 
effect in childhood populations (Ohlund et al., 2007). Similarly, Gedalia et al. (1991) showed 
that the consumption of hard cheese lead to significant rehardening of softened enamel 
surfaces by a cola type drink while a cheese with Lactobacillus rhamnosus as probiotic 
diminished caries-associated salivary microbial counts in young adults (Ahola et al., 2002). 
Although more research is needed to elucidate the precise mechanisms for the cariostatic 
effects of cheese, there is enough evidence to support the consumption of cheese as an 
anticaries measure (European Food Safety Agency, 2008). The most plausible mechanism is 
related to the mineralization potential of the casein-calcium phosphate of cheese, to the 
stimulation of saliva flow induced by its texture, the buffering effects of cheese proteins on 
acid formation in dental plaque and the inhibition of cariogenic bacteria (O’Brien and 
O’Connor 2004). 
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One particular characteristic of cheese´s calcium is its high bioavailavility. The 
suggested factors responsible for it are the prevention of the formation of insoluble calcium 
salts in the intestine by casein phosphopeptides (CPPs) (Kitts et al., 1992) and the optimal 
calcium:phosphorus ratio (Cámara-Martos et al., 2013). In ripened cheeses, calcium 
availability is determined by fat content, being lower in full-fat cheeses (13.85%) than in 
semi-fat cheeses (24.13%) (Ibeagha-Awemu et al., 2009). On the other hand, recent studies 
suggest that the use of probiotic cultures in the production of cheese increase the availability 
of calcium, magnesium, and phosphorus. The stimulating effect of probiotic cultures on the 
availability of mineral compounds can be attributed to intensified enzymatic conversion, 
mainly proteolysis and lipolysis (Aljewicz et al., 2014). 
 
11.4. Biological effects of cheese vitamins 
As with other nutrients, the vitamin content is highly variable between types of cheese 
depending on its fat content. Most of the fat-soluble vitamins in milk are retained in the 
cheese fat. Absorption of vitamin A and other fat soluble vitamins such as vitamins D, E and 
K, are increased in the body by the presence of fats in the diet, making cheese a good vehicle 
to deliver them. It has been reported that cheese can provide one third of the reference nutrient 
intake of vitamin A, a vitamin with an important role for the normal functioning of the 
immune system, in the gene expression regulation and sustaining low-light vision (Russell 
2000). 
With regard to the water-soluble vitamins, such as riboflavin, vitamin B12 (niacin) and 
folate, their content in cheese is lower than in milk. However, the loss of some B vitamins is 
compensated by the microbial synthesis during ripening. A portion of a semi hard cheese will 
provide the average male and female adult with 80% for vitamin B12. This vitamin and folic 
acid will help to reduce high levels of homocysteine in blood, an amino acid that has been 
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linked with CVD (Quinlivan et al., 2002). It must be highlighted that ovine milk is richer than 
cow’s milk in most vitamins, and therefore 90 g of sheep milk cheese could cover completely 
the daily requirements for riboflavin (Recio et al., 2009). 
 
11.5. Cheese bioactive proteins and peptides 
The content of proteins present in cheese depends upon the variety, ranging from 4% 
(cream cheese) to 40% (Parmesan cheese). Proteins are one of the major responsible for the 
nutritional, physicochemical, functional and sensory aspects of cheese. In addition, cheese 
protein is almost 100% digestible, as the ripening phase of cheese manufacture involves a 
progressive breakdown of casein by enzymes present in milk and those derived from rennet or 
microorganisms, releasing both amino acids and peptides. Interestingly, lysine is one of the 
major amino acids contained in cheese which bioavailability is very high because of the 
absence of Maillard reactions (de la Fuente and Juárez 2001). The type and quantity of milk 
proteins-derived peptides is affected by factors influencing proteolysis, such as pH, type of 
enzymes, salt-to-moisture ratio, humidity, and storage time and temperature (Park and Jin 
1998). In this sense, different varieties of cheeses are likely to exhibit peptides with variable 
bioactivities, such as antihypertensive, antioxidant, opioid, antimicrobial, anti-proliferative 
and mineral absorption modulatory effects, among others (López-Expósito et al., 2012).  
 
11.5.1. Antihypertensive peptides 
Hypertension is a chronic condition affecting up to 30% of the adult population in the 
developed countries that can lead to more severe and deadly diseases such as stroke and 
coronary heart disease (Chen et al., 2009). One of the many physiological pathways that 
control blood pressure in the human body is the renin-angiotensin-aldosterone system. A key 
component of this system is the Angiotensin I-converting enzyme (ACE) that catalyzes the 
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conversion of angiotensin I into the potent vasoconstrictor angiotensin II and, simultaneously, 
the degradation of vasodilators bradykinin and kallidin. These two reactions cause a 
contraction of the blood vessels and the release of aldosterone, increasing sodium 
concentration and blood pressure. Thus, inhibiting this enzyme can lead to an 
antihypertensive effect. Most of hypertensive patients are treated worldwide with ACE-
inhibitory drugs such as Captopril or Enalapril (Nussberger 2007). However, it has been 
demonstrated that small reductions in average blood pressure may be obtained by nutritional 
measures such as reducing sodium intake and increasing daily consumption of food-derived 
ACE-inhibitory peptides (Sieber et al., 2010). Because of its content of sequences released 
during milk fermentation and ripening, cheese has been extensively studied as potential 
source of ACE-inhibitory peptides. As it is shown in Table 3, the water and/or ethanol soluble 
extracts (WSE, ESE) of many cheese varieties have been obtained and evaluated for their 
ACE-inhibitory properties. The influence of addition of certain probiotic strains (Ong and 
Shah 2008; Wang et al., 2011) or simulated gastrointestinal digestion (Parrot et al., 2003) on 
the ACE-inhibitory activity of different kind of cheeses has been also studied. In some 
studies, different fractionation steps have been performed to purify novel bioactive fragments 
in which their ACE-inhibitory activities have been evaluated. As an example, this strategy has 
been applied to isolated peptides from Manchego cheese (Gómez-Ruiz et al., 2004a, b) and 
other Spanish cheeses such as Cabrales, Mahon, Idiazabal, and Roncal (Gómez-Ruiz et al., 
2006). These authors applied tandem mass spectrometry (MS/MS) to identify and quantify 
sequences contained in those cheese varieties. Some of them, derived from αs1- and β-casein 
showed moderate ACE-inhibitory activity, indicating their potential contribution on the 
activity reported for the cheese WSE (Gómez-Ruiz et al. 2006). MS/MS technique has been 
also found useful to confirm the presence, in cheese samples, of peptides previously identified 
in other milk products obtained by enzymatic hydrolysis or fermentation. Antihypertensive β-
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casein peptides VPP and IPP have been found in different cheese varieties, such as 
Appenzeller, Brie, Caprine, Cheddar, Edam, Fontina, Gouda, Gorgonzola, and Gruyere, 
among others (Bütikofer et al., 2007; Stuknytè et al., 2015). Interestingly, some of these 
varieties contained similar concentrate ions of VPP and IPP than fermented milk products 
with blood-pressure-lowering capacity. Similarly, antihypertensive αs1-casein derived 
peptides AYFYPEL and RYLGY, identified and characterized from casein hydrolyzate by 
Contreras et al. (2009, 2013), were found in several cheese varieties, such as Brie, Caprino, 
Cheddar, Gorgonzola, and Maasdam (Stuknytè et al. 2015). Although several cheeses extracts 
have been characterized by their potent ACE-inhibitory activity, and the presence of 
antihypertensive peptides has been detected in some of them, confirmation of the 
antihypertensive effect of cheese in animal models or humans is still needed. 
 
11.5.2. Antioxidant peptides 
 Oxidative stress, caused by an increased production of reactive oxygen species (ROS) 
associated with a decreased antioxidant capability of the cell, is thought to contribute to the 
pathogenesis of a number of human diseases including CVD, metabolic, inflammatory, 
neurodegenerative diseases and cancer, in addition to accelerate the aging process (Stadtman 
2004). Natural antioxidants provide additional benefits to the endogenous defense strategies 
in the battle against oxidative stress (Erdmann et al., 2008), with food derived peptides being 
potent antioxidants without important side effects (Sarmadi and Ismail 2010). Among them, 
milk proteins have been one of the most frequently studied sources. 
First studies reporting antioxidant activity of cheese-derived peptides were carried out 
with raw and sterilized ovine and caprine cheese like systems coagulated with enzymes from 
the plant Cynara cardunculus (Silva et al., 2006), although sequences of those peptides were 
not identified. Gupta et al. (2009) assessed the antioxidant activity of peptides in WSEs 
11 
 
obtained from Cheddar cheese prepared with Lactobacillus casei ssp. casei 300, Lactobacillus 
paracasei ssp. paracasei 22, and without adjunct cultures by three different methods based on 
radical scavenging activity. In all cheese samples, changes in the antioxidant activity 
correlated to the rate of formation of soluble peptides (proteolysis). Later on, Pritchard et al. 
(2010), Silva et al. (2012), and Bottesini et al. (2013) evaluated the radical scavenging 
activity of WSEs obtained from Australian Cheddar, Brazilian artisanal ‘‘Coalho’’ and 
Parmigiano-Reggiano cheeses, respectively. Gupta et al. (2010) identified two peptides 
corresponding to bovine β-casein (VKEAMAPK) and αs1-casein (HIQKEDVPSER) whose 
potent radical scavenging activity indicated their key contribution on the antioxidant activity 
of Cheddar cheeses. Meister Meira et al. (2012) also identified peptides released during 
manufacture of a Roquefort-type cheese with sequences sharing great homology with peptides 
characterized previously by their antioxidant activity. Recently, three peptides derived from 
αs1- and β-casein have been identified in a Burgos type cheese (Timón et al., 2014). One of 
them, corresponding to αs1-casein (SDIPNPIGSENSEKTTPLLW) is a new peptide with 
potential antioxidant activity. These preliminary results suggest the potential of cheese as 
source of antioxidant peptides, although animal models and human trials confirming these 
effects are needed.   
 
11.5.3. Effects of cheese-derived peptides on nervous system 
Opioid peptides are defined as opioid µ-receptor ligands with agonistic and 
antagonistic activities. Opioid receptors are located in the nervous, endocrine and immune 
systems as well as in the gastrointestinal tract of mammals (Teschemacher 2003). The most 
studied milk-derived opioid receptor ligands are those termed β-casomorphins (BCMs), 
derived from β-casein. They are characterized by the presence of a tyrosine residue at the N-
terminal and another aromatic amino acid at third or fourth position which is an important 
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structural motif that fits into the binding site of opioid receptors (Nagpal et al., 2011). In 
addition to their effects on the central nervous system, BCMs have demonstrated to induce 
intestinal mucus secretion (Plaisancié et al., 2013), increase plasma insulin level, decrease 
glucagon level, and to elevate the activity of superoxide dismutase and catalase (Yin et al., 
2010). Furthermore, they also have been observed to prolong gastrointestinal transit time and 
to exert an anti-diarrheal action in both animals and humans (Daniel et al., 1990). Other 
beneficial activities attributed to BCMs can be found in Ul Haq et al. (2014). 
Only a few studies deal on the presence and levels of BCMs in cheeses. BCM7 [β-
casein (60-66)] and BCM5 [β-casein (60-64)] have been identified in extracts from Brie and 
Gouda cheeses, respectively (Jarmolowska et al., 1999; Kostyra et al. 2004). Also, the content 
of agonistic BCM7 and BCM5, and antagonistic casoxin-6 and casoxin-C (derived from 
bovine κ-casein), and lactoferroxin A (derived from lactoferrin) opioid peptides in three semi-
hard, Edamski, Gouda and Kasztelan, and in two ripening mould cheeses, Brie and Rokpol, 
was evaluated by Sienkiewicz-Szlapka et al. (2009). It was found that the content of BCMs 
was higher in mould cheeses than in semi-hard cheeses which contained fairly high amount of 
casoxin-6. All the extracts, except that from Gouda, were found to affect the intestinal 
mobility in isolated rabbit ileum similarly to morphine, with this effect being reversed by 
naloxone. Similarly, Gorgonzola, Caprino, Brie, Taleggio, Gouda, Fontina, Cheddar and 
Grana Padano cheeses as well as their digests have been analyzed by De Noni and Cataneo 
(2010) for the presence of BCM7 and BCM5. BCM7 was detected in all the cheeses evaluated 
with the exception of Taleggio, Caprino and Grana Padano samples. However, BCM5 was not 
found in any of them.  
Peptides incorporating the BCM7 sequence, which could act as precursors during 
further digestion processes, have also been found in cheeses such as Parmigiano Reggiano 
(Addeo et al., 1992), Cheddar and Jarlsberg (Stepaniak et al,. 1995), and Crescenza (Smacchi 
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and Gobetti 1998). BCM9 [β-casein (60-68)] and a number of peptides including the BCM7 
sequence were identified in Cheddar cheese by Singh et al. (1995, 1997). BCM9 was also 
found in Gouda cheese by Saito et al. (2000). This finding was later on confirmed by 
Toelstede et al. (2008) who described the presence of BCM10 [β-casein (60-69)] in the WSE 
of a matured Gouda cheese. The caprine analoge of BCM9 was also detected in the WSEs of 
Caprino de Piemonte, an Italian goat cheese (Rizzello et al., 2005). 
Relatively little is known about the actual bioavailability of this kind of peptides. 
BCMs have been detected in the plasma of newborn calves after milk intake (Umbach et al., 
1985), and in plasma in 2- and 4- week old pups after ingesting a casein-based formula (Singh 
et al., 1999). As for humans, immunoreactive material to human and bovine BCM7  and 
BCM5  has been detected in the plasma of infants fed with human and cow´s milk (Kost et 
al., 2009; Wasilewska et al., 2011), although the method of detection employed by the 
authors raise many doubts regarding the cross-reactivity of the antibody with some other 
epitopes of antigen present in plasma. In any case, authors speculated that the intestinal 
mucosa of the newborn is more permeable to the relatively large peptides due to their 
immature tight junction through which peptides cross, thereby escaping hydrolysis by brush-
border peptidases (Sienkiewicz-Szlapka et al., 2009). It is necessary to continue exploring the 
role of BCMs in human health applying in vivo experiments with improved diagnostic 
techniques to verify their presence in the blood. Furthermore, more research needs to be done 
aimed to evaluate the absorption of these peptides in a complex food matrix such as cheese. 
 
11.5.4. Antiproliferative peptides 
There are several studies demonstrating the ability of bovine milk proteins such as 
lactoferrin and lactoferricin to suppress the growth of cancer cells both in vitro and in vivo by 
serving as apoptotic inducers in tumor development (Roy et al., 2002; de Moreno de LeBlanc 
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et al., 2005; Mader et al., 2005). However, regarding cheese, any peptides with 
antiproliferative properties have been yet characterized. To date, the antiproliferative effects 
of cheese extracts are being evaluated and all the described results are based on either cheese 
extracts or cheese whey. The potential role of 12 commercial cheese products on the cell 
growth and induction of DNA fragmentation in HL-60 human promyelocytic leukemia cells 
was investigated by Yasuda et al. (2010). Among them, extracts from Montagnard, Pont- 
l´Eveque, Brie, Camembert, Danablue and Blue cheeses revealed the highest activity. In 
addition, a positive correlation between the ripeness of various cheeses and their 
antiproliferative activity was found. It remains to be elucidated whether these active 
molecules from cheeses may be present at enough concentration to exert their activity, as well 
as their bioavailability and the specificity to cancer cells. 
Mozzarella whey samples produced a 43% reduction in cell proliferation in Caco 2 
cells (De Simone et al., 2009). The absence of this effect in the peptide extract from original 
milk suggested that the release of specific bioactive compounds occurs specifically during the 
cheese’s production process. Later on, it was identified a partially RP-HPLC purified peptide 
sub-fraction as the responsible of the activity observed (De Simone et al., 2011). On the 
mentioned sub-fraction, a number of peptides mainly derived from κ-casein glyco-
caseinmacropeptide, and β-casein were identified by MALDI-TOF/MS.  
 
11.5.5. Antimicrobial peptides 
The majority of antimicrobial peptides derived from food sources have been identified 
in milk, milk hydrolysates and fermented milks (López-Expósito and Recio 2006). However, 
there is almost no information considering the potential of cheese as a source of antimicrobial 
peptides. To date, all the publications dealing with the antimicrobial properties of cheese are 
based on WSEs, and very few of them identify the potential peptides responsible (Rizello et 
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al., 2005; Losito et al., 2006, Lignitto et al., 2012). Because cheese´s WSE also contain 
organic acids and salts that could contribute to the inhibition of microbial growth, it is 
important to perform a purification step to remove them, prior to attributing to peptides the 
potential antimicrobial activity observed. Recently, Théolier et al. (2014) evaluated the 
antibacterial activity of WSEs from five commercial cheeses namely Mozzarella, Gouda, 
Swiss, and old and medium Cheddar. Before purification through a Sep-Pak cleanup column, 
WSEs from Mozzarella and Gouda cheeses inhibited the growth of Listeria ivanovii HPB28, 
L. monocytogenes Scott A3, Escherichia coli MC4100 and E. coli O157:H7  up to 4.66 log 
cycles. However, after desalting, the activity against L. monocytogenes Scott A3 and E. coli 
O157:H7 was almost negligible, highlighting the importance of carrying out a previous 
purification step. The same purified WSEs demonstrated to induce a delay in spore 
germination of several food-borne molds, reaching the lowest minimal inhibitory 
concentration values against Penicillium camemberti and P. commune strains, for Swiss, 
Gouda and Mozzarella extracts. Purified WSE of Asiago d´Allevo cheese displayed moderate 
antibacterial properties against L. innocua LRGIA01 growth (Lignitto et al., 2012; Thi et al., 
2014). The bacterial growth inhibitory properties were affected by the ripening time with the 
highest activities observed after 6 months of maturation. Authors identified a big number of 
casein derived peptides present in the WSE, among which they found other potent 
antimicrobial fragments previously described such as isracidin [αs1-casein (1-23)] (Hill et al., 
1974) and αs2-casein (183-207) (López-Expósito et al., 2006). Similarly, Losito et al. (2006) 
identified more than 30 peptides with a high level of homology with N-terminal, C-terminal 
or whole fragments of previously reported milk derived antimicrobial sequences from the 
WSEs of Pecorino Romano, Canestrato Pugliese, Crescenza, Caprino del Piemonte and 
Caciocavallo cheese varieties (Rizzello et al., 2005). Recently, the antibacterial activity 
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against L. monocytogenes strain 162 of Emmental de Savoie purified WSE has also been 
reported (Thi et al., 2014), although there was not identification of the responsible peptides. 
To date, there are not any in vivo published data supporting the antimicrobial effects of 
cheese consumption. However, some data regarding the in vivo antimicrobial activity of one 
of the peptides identified in cheese extracts, isracidin, have been published (Lahov and 
Regelson, 1996). In mice, it exerts a protective effect against L. monocytogenes, 
Streptococcus pyogenes and Staphylococcus aureus. Also, in cows with mastitis, isracidin 
obtained a success rate of over 80% in the treatment of chronic streptococcal infection. 
 
11.5.6. Modulatory peptides of mineral absorptions: Phosphopeptides 
 CPPs are bioactive peptides with various degrees of phosphorylation which are 
released in vitro and in vivo by enzymatic hydrolysis of the different casein fractions 
(Bouhallab and Bouglé 2004; Phelan et al., 2009). As these peptides have a high net negative 
charge, they efficiently bind divalent cations with the formation of soluble complexes. This 
property makes these peptides perfect candidates as anticariogenic compounds (Cochrane and 
Reynolds 2009).  
Apart from the metal binding properties, CPPs have other bioactive properties such as 
antioxidant (Kitts 2005), immunostimulatory (Kitts and Nakamura 2006), gastric secretion 
regulatory (Guilloteau et al., 2009), antimicrobial (Arunachalam and Raja 2010), and 
stimulatory activity of growth and differentiation of osteoblastic cells (Tulipano et al., 2010).  
In the last years, several studies have isolated, characterized and identified CPPs from 
different types of cheese (Table 4). The presence of CPPs in these cheese types has been 
investigated by analyzing the total WSEs or using an enrichment step by precipitation. 
Although a number of enzymes are common to many cheese varieties, the peptide 
composition is unique from each cheese type and reflects a characteristic ripening process. In 
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cheeses some of the peptides appeared to be partly dephosphorylated. For instance, Addeo et 
al. (1992) found the αs1-casein (41-75)  partly dephosphorylated, containing only three of the 
seven native phosphate groups in Parmigiano-Reggiano cheese. Singh et al. (1997) observed a 
complete dephosphorylation of the peptide β-casein (8-23), which in intact β-casein contains 
four phosphate groups. These results suggest that phosphatase is active in these varieties of 
cheese, hydrolyzing the native CPPs to phosphate and partly dephosphorylated peptides.  
Moreover, the presence of aminopeptidase activity has been deduced from the 
presence of a number of CPPs of different lengths with the loss of one or more residues from 
the N-terminus (Ferranti et al., 1997). In Comté cheese, the original cleavage of β- and αs2-
casein is due to plasmin, an alkaline milk protease that has a trypsin-like specificity cleaving 
K28-K29 of β-casein and K21-Q22 of αs2-casein. These two peptides are further hydrolyzed by 
the action of another endopeptidase and of an aminopepdidase, as well as of a lysyl 
carboxypeptidase (Roudot-Algaron et al., 1994).  
Therefore, CPPs could be regarded as transient intermediate components in cheese; 
they either accumulate or are degraded by cheese enzymes to shorter peptides and free amino 
acids, including phosphorylated serine. The most of CPPs come from the region (14-28) of β-
casein (Sforza et al., 2003). The accumulation of a specific peptide always depends on a 
delicate balance between producing and degrading enzymes and the availability of the parent 
substrate (Sforza et al., 2012). In the case of Ragusano cheese the number of identified 
soluble peptides dramatically decreased after 4 and 7 months of ripening, from 123 to 47 and 
25, respectively (Gagnaire et al., 2011). 
It has been reported that CPPs are released in the gut and accumulate in the lower part 
of the small intestine (ileum) where mineral absorption takes place (FitzGerald 1998; Zidane 
et al., 2012). Therefore, several in vivo studies have investigated if CPPs could increase 
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mineral absorption, especially Ca2+ absorption. Although these studies provide considerable 
evidence for a potential effect of CPPs to improve mineral absorption, results are still 
controversial (Scholtz-Ahrens and Schrezenmeir 2000; Meisel and FitzGerald 2003; Mills et 
al., 2011). This variability can be due to the diversity of the experimental approaches used to 
assess mineral bioavailability (Korhonen and Pihlanto 2006). Moreover, it seems that results 
may depend on the food matrix (Hansen et al., 1997). On the other hand, the effect of CPPs 
may also be influenced by the physical status of the population (Teucher et al., 2006), the 
levels of CPPs (Bennett et al., 2000) and the ratio calcium:phosphorus present (Erba et al., 
2001, 2002).  
 
11.6. Future prospects 
Cheese constitutes an adequate source of micronutrients and bioactives, which have 
generated extensive investigation for the last six decades. Knowledge of minerals is relatively 
complete and precise. As for vitamins, data are lacking or there is discrepancy between them. 
However, there is no doubt about their important nutritional role and health benefits. As for 
lipid and protein components, beyond their nutritional role, the increased scientific knowledge 
on the biological activities has demonstrated that cheese might provide specific health 
benefits. Questions to be answered include the changes that may occur during processing, the 
role of the different components on the absorption and the interest in enriching cheese with 
micronutrients or bioactives. As an example, there are some reports on the presence of 
bioactive peptides in duodenal effluents from humans upon milk proteins ingestion (Boutrou 
et al., 2013) and even the presence in plasma of the milk bioactive peptides IPP and VPP 
(Foltz et al., 2007) or HLPLP (Sánchez-Rivera et al., 2014) has been demonstrated in vivo. 
However, more research is needed to evaluate the absorption of these peptides in a complex 
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food matrix as cheese. Further intervention studies confirming the beneficial effects of 
cheeses containing bioactive peptides should be also conducted.   
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Table 1. Fatty acid composition (g/100 g) and cis-9, trans-11 CLA content (mg/g fat) of different cheeses elaborated from cow, sheep and goat milk 
Type of milk Cheese type SFAa content 
(%) 
MUFAb content 
(%) 
PUFAc content 
(%) 
Cis-9, trans-11 CLAd 
(mg/g fat) 
Reference 
Cow Alpine 65.23 31.19 3.57 4.79 ± 1.07 Prandini et al. (2007) 
 Asiago n.d. n.d. n.d. 5.91 ± 1.95 Cicognini et al. (2014)f 
 Belpaese n.d. n.d. n.d. 5.22 ± 1.97 Cicognini et al. (2014)f 
 Caciotta n.d. n.d. n.d. 5.98 ± 1.18 Cicognini et al. (2014)f 
 Caciocavallao n.d. n.d. n.d. 5.35 ± 2.77 Cicognini et al. (2014)f 
 Camembert 58.41 25.70 3.20 9.50 ± 0.20 Domagała et al. (2010)g 
 Caprino fresh 66.87 24.45 3.44 6.10 ± 2.65 Prandini et al. (2011) 
 Cheddar n.d. n.d. n.d. 5.86 ± 0.89 Cicognini et al. (2014)f 
 Crescenza n.d. n.d. n.d. 4.76 ± 0.79 Cicognini et al. (2014)f 
 Dziurawiec 58.27 21.72 2.55 9.00 ± 0.90 Domagała et al. (2010)g 
 Emmentaler 57.88 25.36 3.06 7.40 ± 0.10 Domagała et al. (2010)g 
 Swiss Emmental 66.67 29.85 3.48 7.66 ± 1.42 Prandini et al. (2007 
 Fontina Valdostana 67.26 28.57 4.17 8.11 ± 1.53 Prandini et al. (2007) 
 Gorgonzola 64.10 25.79 3.92 5.16 ± 0.29 Prandini et al. (2011) 
 Gouda 56.38 24.89 3.45 12.00 ± 0.70 Domagała et al. (2010)g 
 Gouda n.d. n.d. n.d. 4.32 ± 1.43 Cicognini et al. (2014)f 
 Grana/Parmigiano 68.52 27.90 3.58 3.85 ± 0.51 Prandini et al. (2007) 
 Gruyere n.d. n.d. n.d. 10.21 ± 2.47 Cicognini et al. (2014)f 
 Mazdamer 56.05 26.51 3.20 9.80 ± 0.30 Domagała et al. (2010)g 
 Montasio n.d. n.d. n.d. 4.78 ± 1.23 Cicognini et al. (2014)f 
 Mozzarella 67.04 29.20 3.75 0.24 ± 0.01e Caroprese et al. (2013)h 
 Parmigiano 59.77 22.77 3.60 4.40 ± 0.20 Domagała et al. (2010)g 
 Philadelphia n.d. n.d. n.d. 5.41 ± 1.15 Cicognini et al. (2014)f 
 Prato n.d. n.d. n.d. 3.79 ± 0.50 Cortes Nunes and Guedes 
Torres (2010)i 
 Provola n.d. n.d. n.d. 6.96 ± 5.12 Cicognini et al. (2014)f 
 Provolone n.d. n.d. n.d. 4.92 ± 0.23 Cicognini et al. (2014)f 
 Radamer 57.74 25.86 2.94 7.10 ± 0.50 Domagała et al. (2010)g 
 Ricotta n.d. n.d. n.d. 5.53 ± 1.08 Cicognini et al. (2014)f 
 Robiola n.d. n.d. n.d. 4.77 ± 1.26 Cicognini et al. (2014)f 
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 Salami 56.92 25.89 3.33 11.80 ± 0.70 Domagała et al. (2010)g 
 Scamorza n.d. n.d. n.d. 4.93 ± 0.31 Cicognini et al. (2014)f 
 Stracchino n.d. n.d. n.d. 5.01 ± 1.26 Cicognini et al. (2014)f 
Sheep Pecorino 67.69 26.83 5.48 7.77 ± 2.25 Prandini et al. (2007) 
 Pecorino hard 65.94 23.80 4.93 10.90 ± 0.03 Prandini et al. (2011) 
 Roquefort 70.10 21.11 3.92 8.81 ± 3.84 Prandini et al. (2011) 
 Feta 70.20 21.00 4.70 9.24 ± 4.80 Zlatanos et al. (2002)j 
 Feta n.d. n.d. n.d. 8.50 ± 1.95 Cicognini et al. (2014)f 
 Rokpol 55.47 27.55 3.71 13.10 ± 0.10 Domagała et al. (2010)g 
Goat Caprino fresh 66.92 23.89 4.08 6.80 ± 1.26 Prandini et al. (2011) 
 Caprino hard 67.06 23.71 4.23 7.06 ± 3.42 Prandini et al. (2011) 
 
a Saturated fatty acids; b Monounsaturated fatty acids; c Polyunsaturated fatty acids; d Conjugated linoleic acid; e expressed as g of isomer/100 g fatty acids; n.d. not detected; 
. 
f Cicognini, F. M., Rossi, F., Sigolo, S., Gallo, A., Prandini, A., 2014. Conjugated linoleic acid isomer (cis9,trans11 and trans10,cis12) content in cheeses from Italian large-
scale retail trade. International Dairy Journal 34, 180-183. 
g Domagała, J., Sady, M., Grega, T., Pustkowiak, R., Florkiewicz, A., 2010. The influence of cheese type and fat extraction method on the content of conjugated linoleic acid. 
Journal of Food Composition and Analysis 23, 238-243. 
h Caroprese, M., Sevi, A., Marino, R., Santillo, A., Tateo, A., Albenzio, M., 2013. Composition and textural properties of Mozzarella cheese naturally-enriched in 
polyunsaturated fatty acids. Journal of Dairy Research 80, 276-282. 
i Cortes Nunes, J., Guedes Torres, A., 2010. Fatty acid and CLA composition of Brazilian dairy products, and contribution to daily intake of CLA. Journal of Food 
Composition and Analysis 23, 782-789. 
j Zlatanos, S., Laskaridis, K., Feist, C., Sagredosa, A., 2002. CLA content and fatty acid composition of Greek Feta and hard cheeses. Food Chemistry 78, 471-477. 
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Table 2. Levels of minerals of different international cheeses, mg/serving portion of 30 g  
 
 Calcium  Magnesium Phosphorus Sodium Potassium  Iron Reference 
Camembert 116 6.0 104 253 56 0.10 Gaucheron 2011b 
% DVa 11 2 10 10 1 1  
Cheddar 216 8.4 154 186 29 0.20 Gaucheron 2011b 
% DVa 20 2 15 7 1 1  
Feta 147 5.7 101 335 19 0.19 Gaucheron 2011b 
% DVa 14 2 10 12 1 1  
Gouda 210 8.7 164 246 36 0.07 Gaucheron 2011b 
% DVa 20 2 16 9 1 1  
Gruyêre 303 10.8 182 101 24 0.05 Gaucheron 2011b 
% DVa 29 3 19 4 1 1  
Idiazabal 295 14.3 188 166 33 0.19 Cámara-Martos et al., 2013 
% DVa 29 4 19 7 1 1  
Manchego 278 13.2 177 197 31 0.13 Cámara-Martos et al., 2013 
% DVa 27 4 18 8 1 1  
Parmigiano 413 15.3 242 558 32 0.29 Gaucheron 2011b 
% DVa 39 4 23 22 1 1  
Roquefort 199 9.0 118 543 27 0.17 Gaucheron 2011b 
% DVa 20 2 14 22 1 1  
Tetilla 243 9.5 154 162 31 0.08 Cámara-Martos et al., 2013 
% DVa 24 2 15 6 1 1  
Torta del Casar 158 9.9 117 161 34 0.16 Cámara-Martos et al., 2013 
% DVa 15 3 12 6 1 1  
a Percentage of daily value, %DV, based on energy and nutrient recommendations for a general 2000-calorie diet 
b Gaucheron, F., 2011. Milk and dairy products: A unique micronutrient combination. Journal of the American College of Nutrition 30, 400-409. 
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Table 3. Angiotensin I-converting enzyme inhibitory activity of different cheese varieties and peptides identified as potentially responsible for the observed 
effects 
 
Type of cheese Analyzed sample 
ACE inhibitory 
activity Identified peptides Reference 
(%) IC50 (mg/mL) 
Appenzeller 
Classic, 3-month old 
Surchoix, 4-month old  
Extra, 6-7-month old  
1/4 fat, 3-month old 
1/4 fat, 7-10-month old  
 
WSEa 
WSEa 
WSEa 
WSEa 
WSEa 
  
17.6 
8.0 
16.8 
7.1 
4.2 
 
VPP; IPP 
VPP; IPP 
VPP; IPP 
VPP; IPP 
VPP; IPP 
Bütikofer et al., 2007 
Brie WSEa 
WSEa 
 25.9 VPP; IPP 
VPP; IPP; RYLG; RYLGY; HLPLP; LHLPLP 
Bütikofer et al., 2007 
Stuknytè et al., 2015 
Cabrales WSEa 
Fraction ˂ 1 kDa 
74.7 
76.1 
 PP; MPI; MPL; EVVR; REL; DKIHP; DKIHPF; FPGPIH; PGPIH; 
GPIH; PVEP; PVEPF 
Gómez-Ruiz et al., 
2006 
Caprino WSEa   VPP; IPP; RYLG; RYLGY; AYFYPEL; LHLPLP Stuknytè et al., 2015 
Cheddar 
 
+ Lb. casei LAFTI® L26 
(36 weeks) 
+ Lb. acidophilus 
LAFTI® L10 (24 weeks) 
WSEa 
 
WSEa 
 
WSEa 
 
 
~82 
 
 
0.25 
 
0.13 
VPP; IPP; RYLG; RYLGY; HLPLP; AYFYPEL; LHLPLP 
RPKHPIKHQ; RPKHPIK; RPKHPI; DKIHPF; FVAPFPEVF; 
KKYKVPQLE; YQEPVLGPVRGPFPIIV 
ARHPHPH; RPKHPIKHQ; RPKHPIK; RPKHPI; FVAPFPEVF; 
YQEPVLGPVRGPFPIIV 
Stuknytè et al., 2015 
 
Ong et al., 2007d 
 
Ong and Shah 2008 
Crescenza FPLC fraction 37  LVYPFPGPIHNSLPQ Smacchi and Gobbetti 
1998 
Edam WSEa  13.3 VPP; IPP Bütikofer et al., 2007 
Emmental 
Classic, 4-month old 
Organic, 4-month old  
Reserved, 8-month old 
Cave-aged, 12-month old 
WSEa 
WSEa 
WSEa 
WSEa 
WSEa 
  
10.5 
7.5 
9.9 
7.1 
VPP; IPP 
VPP; IPP 
VPP; IPP 
VPP; IPP 
VPP; IPP 
Stuknytè et al., 2015 
Bütikofer et al., 2007 
Feta WSEa  14.3 VPP; IPP Bütikofer et al., 2007 
Fontina WSEa   VPP; IPP; HLPLP Stuknytè et al., 2015 
Gamalost WSEa ~77 
~70 
~2.5 
~0.5 
SLVYPFPGPIPNSLPQNIPPLTQTPVVVPPFLQPEVM; 
VYPFPGPIPNSLPQNIPPLTQTPVVVPPFLQPE; 
HKEMPFPKYPVEPFT; SLTLTDVENLHLPLPLL; NLHLPLPLL; 
Qureshi et al., 2013e 
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HLPLPLLQ; WMHQPHQPLPPTVMFPPQSVL; 
FLLYQEPVLGPVRGPFPIIV 
Goat cheese WSEa  
Fraction ˂ 1 kDa 
72.8 
59.4 
 QP; PP; RPK; EEL; EEI; DKIHP; DKIHPF; PLTQTP; VVVPP; 
GVPK; TDVEK; VRGP 
Gómez-Ruiz et al., 
2006 
Gouda 
8-month old  
 
Old 
WSEa 
WSEa 
 
WSEa 
 
75.7c 
 
 
 
2.0 
VPP; IPP 
RPKHPIKHQ; RPKHPIKHQGLPQ; YPFPGPIPN; 
MPFPKYPVQPF 
VPP; IPP 
Stuknytè et al., 2015 
Saito et al., 2000 
 
Bütikofer et al., 2007 
Gorgonzola WSEa 
WSEa 
 21.8 VPP; IPP 
VPP; IPP; AYFYPE; HLPLP; AYFYPEL; LHLPLP 
Bütikofer et al., 2007 
Stuknytè et al., 2015 
Grana Padano WSEa   VPP; IPP; RYLG; HLPLP; LHLPLP Stuknytè et al., 2015 
Graubünden-full fat  
Graubünden-½ fat  
Graubünden-¼ fat  
WSEa 
WSEa 
WSEa 
 9.2 
8.9 
4.8 
VPP; IPP 
VPP; IPP 
VPP; IPP 
Bütikofer et al., 2007 
Gruyere-5-month old  
Gruyere-8-month old  
Gruyere-10-month old  
Gruyere-12-month old  
WSEa 
WSEa 
WSEa 
WSEa 
 14.9 
18.7 
14.2 
29.4 
VPP; IPP 
VPP; IPP 
VPP; IPP 
VPP; IPP 
Bütikofer et al., 2007 
Hobelkäse WSEa  2.6 VPP; IPP Bütikofer et al., 2007 
Idiazabal WSEa  
Fraction ˂ 1 kDa 
WSEa and ESEb 
87.5 
68.5 
 QP; FP; NINE; PSE; ERYL; PQL; EIVPK; AWY; DKIHP; DKIHPF 
QNALIVRYTR; KALPMHIRLAF; EGPKLVAS; 
PVGLVQPASATLYDY; KVGTKCCAKP; REKVLASS; 
PKIDAMREKVLA; PRKEKLCTTS; YQEPVLGPVRG; 
NAGPFTPTVNREQLSTS 
Gómez-Ruiz et al., 
2006 
 
Sagardia et al., 2013f 
Küsnachter WSEa  19.6 VPP; IPP Bütikofer et al., 2007 
Limburger WSEa  6.4 VPP; IPP Bütikofer et al., 2007 
Maasdam WSEa   VPP; IPP; HLPLP; AYFYPEL; LHLPLP Stuknytè et al., 2015 
Mahon WSEa  
Fraction ˂ 1 kDa 
76.8 
56.6 
 PK; PQ; RI; RL; PQEVL; EVLN; NENLL; ENLL; NLLRF Gómez-Ruiz et al., 
2006 
Manchego WSEa  
Fraction ˂ 1 kDa 
 
 
 
WSEb 
70.6 
65.3 
 
 
 
 
 
29.5 
QP; PP; FP; PFP; HPIK; HQGL; DKIHP; DKIHPF; TGPIPN; 
VRYL; VPSERYL; VPSERY; DVPSERYLG; KKYNVPQL; 
KKYNVPQ; IPY; TQOKTNAIPY; VRGPFP; PVRGPF; LEIVPK; 
RPKHPI; VPKVKE; REQEEL; DVPSERY; VRGPFP; LPQNILP 
VPP; IPP 
Gómez-Ruiz et al., 
2004a,b, 2006 
 
 
 
Bütikofer et al., 2007 
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Mexican + Lb. casei 
 
Mexican + En. faecium 
WSEa 
 
WSEa 
95.5 
 
96.3 
5.3 
 
10.4 
YQEPVLGPVRGPFPI; YQEPVLGPVRGPFPIIV; 
FVAPFPEVFGK; EVLNENLLRF 
YQEPVLGPVRGPFPIIV; RPKHPIKHQGLPQEV; 
RPKHPIKHQGLPQEVLNENLLR;    FVAPFPEVFGK; 
EVLNENLLRF 
Torres-Llanez et al., 
2011g 
Münster WSEa  14.1 VPP; IPP Bütikofer et al., 2007 
Parmino WSEa  28.6 VPP; IPP Bütikofer et al., 2007 
Provolone WSEa   VPP; IPP; RYLG; LHLPLP Stuknytè et al., 2015 
Provolone picante WSEa   VPP; IPP; RYLG; LHLPLP Stuknytè et al., 2015 
Raclette-raw milk  
Raclette-pasteurized milk  
WSEa 
WSEa 
 8.8 
9.0 
VPP; IPP 
VPP; IPP 
Bütikofer et al., 2007 
Reblonchon WSEa  17.0 VPP; IPP Bütikofer et al., 2007 
Roncal WSEa  
Fraction ˂ 1 kDa 
85.8 
70.4 
 QP; PP; RPKHP; PKHP; HPIK; HQGL; DKIHP; DKIHPF; GPVR Gómez-Ruiz et al., 
2006 
Roquefort WSEa  10.2 VPP; IPP Bütikofer et al., 2007 
Roquefort-type cheese WSEa  0.34 KEMPFPKYPVE; WMHQPPQPLPPTVMFPPQSVL; 
MHQPPQPLPPTVMFPPQSVL; HQPPQPLPPTVMFPPQSVL; 
YQEPVLGPVRGPFPI; QEPVLGPVRGPFPILV; 
QEPVLGPVRGPFPI; PVLGPVRGPFPI; LGPVRGPFPI; 
TDAPSFSDIPNPIGSENSGK; DIPNPIGSENSGKTTMPLW; 
IPNPIGSENSGKIT; NAGPFTPTVNR; YQGPIVLNPWDQVKR; 
YQGPIVLNPWDQVK; GPIVLNPWDQVKR; VLNPWDQVKR 
Meister Meira et al., 
2012 
St. Paulin WSEa  23.5 VPP; IPP Bütikofer et al., 2007 
Sbrinz WSEa  16.4 VPP; IPP Bütikofer et al., 2007 
Taleggio WSEa   VPP; IPP; HLPLP Stuknytè et al., 2015 
Tete de Moine WSEa  7.1 VPP; IPP Bütikofer et al., 2007 
Tilsit-raw milk  
Tilsit-pasteurized milk  
WSEa 
WSEa 
 4.4 
18.0 
VPP; IPP 
VPP; IPP 
Bütikofer et al., 2007 
Vacherin fribourgeois 
Vacherin Mont d’Or 
WSEa 
WSEa 
 5.0 
21.4 
VPP; IPP 
VPP; IPP 
Bütikofer et al., 2007 
Wangener Geissmutschli WSEa  7.9 VPP; IPP Bütikofer et al., 2007 
Winzerkäse WSEa  9.9 VPP; IPP Bütikofer et al., 2007 
 
a Water soluble extract; b Ethanol soluble extract; c Antihypertensive effect in spontaneously hypertensive rats (Dose of 6.1-7.5 mg/kg produces a decrease in Systolic blood 
pressure (SBP) of −24.7mmHg 
d  Ong, L., Henriksson, A., Shah, N. P., 2007. Angiotensin converting enzyme-inhibitory activity in Cheddar cheeses made with the addition of probiotic Lactobacillus casei 
sp. Lait 87, 149-165. 
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e Qureshi, T. M., Vegarudm G. E., Abrahamsen, R. K., Skeie, S., 2013. Angiotensin I-converting enzyme-inhibitory activity of the Norwegian autochthonous cheeses 
Gamalost and Norvegia after in vitro human gastrointestinal digestion. Journal of Dairy Science 96, 838-853. 
f  Sagardia, I., Iloro, I., Elortza, F., Bald, C., 2013. Quantitative structure-activity relationship based screening of bioactive peptides identified in ripened cheese. International 
Dairy Journal 33, 184-190. 
g Torres-Llanez, M. J., González-Córdova, A. F., Hernández-Mendoza, A., Garcia, H. S., Vallejo-Cordoba, B., 2011. Angiotensin-converting enzyme inhibitory activity in 
Mexican Fresco cheese. Journal of Dairy Science 94, 3794-3800. 
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Table 4. Phosphopeptides derived from αs1-, αss- and β-casein identified in different cheese types. Each peptide sequence is described by the one letter code, 
superscripts numbers are referred to the amino acid position into the protein sequence when the number of the amino acids is lower than 25.  
Type of 
cheese 
Analyzed 
sample 
αs1-casein αs2-casein β-casein Reference 
Beaufort-6 
month old 
Enrichment 
by IMAC-
Fe (III) 
67SpSpEEIVPN74 
75SpVEQKHIQK83 
103KYKVPQLEIVPNSpAE117 
104YKVPQLEIVPNSpAEERLH121 
106VPQLEIVPNSpAEERLH121 
106VPQLEIVPNSpAEERLHSMK124 
109LEIVPNSpAEERLH121 
111IVPNSpAEERLH121 
111IVPNSpAEERLHSMK124 
112VPNSpAEERLH121 
114NSpAEERL120 
 
137KTVDMESpTEVFTK149 
137KTVDMESpTEVFTKK150 
137KTVDMESpTEVFTKKT151 
138KTVDMESpTEVFTKK150 
141MESpTEVFTKK150 
143SpTEVFTKK150 
 
12IVESpL16 
14ESpLSpSpSpEESITRIN27 
15SLSpSpSpEESITR25 
15SLSpSpSpEESITRIN27 
16LSpSpSpEESITR25 
16LSSpSpEESITR25 
16LSSpSpEESITRIN27 
17SSpSpEESITRIN27 
17SSpSEESITRIN27 
29KIEKFQSpEE37 
29KIEKFQSpEEQQ39 
29KIEKFQSpEEQQQTE42 
29KIEKFQSpEEQQQTED43 
29KIEKFQSpEEQQQTEDELQ46 
29KIEKFQSpEEQQQTEDELQDK48 
29KIEKFQSpEEQQQTEDELQDKIHPF52 
29KIEKFQSpEEQQQTEDELQDKIHPFAQT55 
30IEKFQSpEEQQQTEDELQDK48 
30IEKFQSpEEQQQTEDELQDKIHPF52 
30IEKFQSpEEQQQTEDELQDKIHPFAQTQ56 
32KFQSpEEQQQTED43 
32KFQSpEEQQQTEDELQD47 
32KFQSpEEQQQTEDELQDKIHPF52 
33FQSpEEQQQTEDELQDKIHPF52 
33FQSpEEQQQTEDELQDKIHPFAQTQ56 
Dupas et 
al., 2009b 
Cheddar 
(mature) WSE
a 
115SpAEERLH121 
115SpAEERLHSMK124 
61SpAEVATEEVK70 7NVPGEIVESLSpSp18 
7NVPGEIVESLSpSpSp19 
10GEIVESp15 
29KIEKFQSpEEQQ39 
29KIEKFQSpEEQQ….QTQ56 
30IEKFQSpE36 
Singh et al., 
1997 
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Emmental- 
2 month old WSE
a 
 1KNTMEHVSpSpSpEESIISpQETYK21 
1KNTMEHVSpSpSpEESIISpQETYKQEK24 
7VSpSpSpEESIISpQETYK21 
16SpQET19 
35LCSTFCKEVVRNA….SpSpSpEESpAEVAT66 
7NVPGEIVESLSpSpSpEESITRINK28 
8VPGEIVESLSpSpSpEESITRINK28 
11EIVESpLSpSpSpEESITRINK28 
11EIVESpLSpSpSpEESITRINKK29 
11EIVESpLSpSpSpEESITRINKKIEK32 
12IVESpLSpSpSpEESITRINK28 
12IVESLSpSpSpEESITRINK28 
13VESLSpSpSpEESITRINK28 
15SpLSpSpSpEESITR25 
15SpLSpSpSpEESITRINK28 
16LSpSpSpEESITR25 
16LSpSpSpEESITRINK28 
18SpSpEESITR25 
Gagnaire et 
al., 2001c 
Grana 
Padano-14 
month old 
Enrichment 
by 
precipitation 
with barium 
nitrate 
61EAESpISpSpSpEEIVPN74 
61EAESpISpSpSpEEIVPNSpVEQK79 
62AESpISpSpSpEEIVPN74 
62AESpISpSpSpEEIVPNSpVEQK79 
63ESpISpSpSpEEIVPN74 
63ESpISpSpSpEEIVPNSpVEQK79 
64SpISpSpSpEEIVPN74 
64SISpSpSpEEIVPN74 
64SpISpSpSpEEIVPNSpVEEK79 
65ISpSpSpEEIVPN74 
65ISSpSpEEIVPN74 
65ISpSpSpEEIVPNSpVEEK79 
67SpSpEEIVPN74 
67SSpEEIVPN74 
 
7VSpSpSpEESIISpQE18 
7VSSpSpEESIISpQE18 
7VSpSpSpEESIISpQET19 
7VSpSpSpEESIISpQETYK21 
8SpSpSpEESIISpQE18 
 
7NVPGEIVESpLSpSpSpEESITRINK28 
12IVESpLSpSpSpEESITR25 
12IVESpLSpSpSpEESITRINK28 
13VESpLSpSpSpEESIT24 
13VESpLSpSpSpEESITR25 
13VESpLSpSpSpEESITRIN27 
13VESpLSpSpSpEESITRINK28 
14ESpLSpSpSpEESIT24 
14ESpLSpSpSpEESITR25 
14ESpLSpSpSpEESITRIN27 
14ESpLSpSpSpEESITRINK28 
15SLSpSpSpEES22 
15SpLSpSpSpEESIT24 
15SLSpSpSpEESIT24 
15SpLSpSpSpEESITR25 
15SpLSpSpSpEESITRIN27 
15SLSpSpSpEESITRIN27 
15SpLSpSpSpEESITRINK28 
15SLSpSpSpEESITRINK28 
16LSpSpSpEES22 
16LSpSpSpEESIT24 
16LSpSpSpEESITR25 
16LSpSpSpEESITRIN27 
16LSpSpSpEESITRINK28 
Ferranti et 
al., 1997 
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Grana 
Padano-2-
23 month 
old 
WSE   14ESLSpSpSpEESITRINK28 
16LSpSpSpEES22 
16LSpSpSpEESITR25 
16LSpSpSpEESITRINK28 
Sforza et 
al., 2003 
Gruyêre de 
Comté-12 
month old 
WSEa  5EHVSpSpSpEESIIS?QETYK21 
6HVSpSpSpEESIISpQETYK21- 
7VSpSpSpEESIIS?QETYK21 
13VESpLSpSpSpEESITRINK28 
13VESLSpSpSpEESITRINK28 
14ESpLSpSpSpEESITRIN27 
14ESpLSpSpSpEESITRINK28 
14ESLSpSpSpEESITRINK28 
15SpLSpSpSpEESITRIN27 
15SLSpSpSpEESITRIN27 
15SpLSpSpSpEESITRINK28 
15SLSpSpSpEESITRINK28 
16LSpSpSpEESITRIN27 
Roudot-
Algaron et 
al., 1994 
Herrgard-10 
month old  
Enrichment 
by IMAC-
Fe (III) 
40LSKDIGSpESpTEDQAME55 
42KDIGSpESpTE50 
42KDIGSpESpTED51 
42KDIGSpESpTEDQAM54 
43DIGSpESpTE50 
43DIGSpESpTED51 
44IGSpE47 
44IGSpESpTE50 
44IGSpESpTED51 
44IGSpESpTEDQ52 
44IGSpESpTEDQAM54 
61EAESpISpSpSpEEIVPNSpVQEK79 
62AESpISpSpSpEEIVPNSpVQEK79 
64SpISpSpSpEEIVPN74 
75SpVEQK79 
75SpVEQKH80 
75SpVEQKHIQ82 
75SpVEQKHIQKE84 
111IVPNSpAEER119 
112VPNSpAE117 
112VPNSpAEER119 
115SpAEER119 
5EHVSpSpSpEESIISpQE18 
5EHVSpSpSpEESIISpQETY20 
5EHVSpSpSpEESIISpQETYK21 
6HVSpSpSpEESIISpQE18 
6HVSpSpSpEESIISpQETYK21 
14IISpQE18 
14IISpQET19 
14IISpQETYK21 
15ISpQET19 
15ISpQETYK21 
16SpQETYK21 
128LSpTSpEE133 
129SpTSEENSpKKTVD140 
141MESpTEVF147 
141MESpTEVFTK149 
 
8VPGEIVESpLSpSpSpEESITRINK28 
10GEIVESpLSpSpSpEESITRINK28 
11EIVESpLSpSpSpEE21 
11EIVESpLSpSpSpEESITRINK28 
12IVESpLSpSpSpEE21 
12IVESpLSpSpSpEES22 
12IVESpLSpSpSpEESITR25 
12IVESpLSpSpSpEESITRINK28 
13VESpLSpSpSpEE21 
13VESpLSpSpSpEESITR25 
15SpLSpSpSpEESITR25 
29KIEKFQSpEEQQQTED43 
29KIEKFQSpEEQQQTEDELQ46 
30IEKFQSpEEQQQ40 
30IEKFQSpE36 
30IEKFQSpEE37 
30IEKFQSpEEQQ39 
30IEKFQSpEEQQQTED43 
30IEKFQSpEEQQQTEDELQ46 
32KFQSpEE37 
32KFQSpEEQ38 
32KFQSpEEQQQTED43 
Lund and 
Ardö, 2004d 
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115SpAEERL120 
115SpAEERLH121 
115SpAEERLHS122 
115SpAEERLHSMK124 
33FQSpE36 
33FQSpEE37 
33FQSpEEQQQ40  
Parmigiano-
Reggiano-2 
month old 
WSEa  3TMEHVSpSpSpEESIISQE…PSKE33 
 
8VPGEIVESpL16 
9PGEIVESpL16 
17SpSpSpEES22 
22SITRYNKKIEKFQSpEEQQQ….KIHPFAQ54 
 
Addeo et 
al., 1992 
Parmigiano-
Reggiano-6 
month old 
WSEa 41SKNIG….SISpSpSpEEIVPNS75 
 
4MEHVSpSpSpEESIISQE…PSKENLC36 
 
 Addeo et 
al., 1992 
Parmigiano-
Reggiano-
15 month 
old 
WSEa  4MEHVSpSpSpEESIISQE…PSKENLC36 
 
 Addeo et 
al., 1992 
Parmigiano-
Reggiano 
(Evolution 
2, 3, 4, 6, 8, 
10, 12, 16, 
20 and 24 
month old 
Enrichment 
by acid 
precipitation  
  11EIVESpLSpSpSpEESITRINK28 
12IVESpLSpSpSpEESITRINK28 
13VESpLSpSpSpEESITRINK28 
14ESpLSpSpSpEESITRINK28 
15SpLSpSpSpEESITRINK28 
15SLSpSpSpEESITRINK28 
16LSpSpSpEESITR25 
16LSpSpSpEESITRINK28 
17SpSpSpEESITR25 
Sforza et 
al., 2012 
Parmigiano-
Reggiano-
24 month 
old 
Enrichment 
by IMAC-
Fe (III) 
64SISpSpSpEEIVPN74 
65ISpSpSpEE70 
65ISpSpSpEEIVPN74 
67SpSpEEIVPN74 
115SpAEERLH121 
115SpAEERLHSMK124 
7VSpSpSpEES13 16LSpSpSpEES22 Lund and 
Ardö 2004d 
Ragusano  WSEa 75SpVEQKHIQKE84 
103KYKVPQLEIVPNSpAE117 
104YKVPQLEIVPNSpAE117 
115SpAEERLHSM123 
1KNTMEHVSpSpSpEESIISpQE18 
1KNTMEHVSpSpSpEESIISpQETYK21 
141MESpTEVFTKK150 
143SpTEVFTKK150 
 
7NVPGEIVESpLSpSpSpEESITRINK28 
15ISLSpSpSpEESITRINK28 
17SpSpSpEESITRINK28 
28KKIEKFQSpEEQQQTEDELQ46 
28KKIEKFQSpEEQQQTEDELQDKIHPF52 
29KIEKFQSpEEQQ39 
Gagnaire et 
al., 2011 
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29KIEKFQSpEEQQQ40 
29KIEKFQSpEEQQQTED43 
29KIEKFQSpEEQQQTEDEL45 
29KIEKFQSpEEQQQTEDELQ46 
29KIEKFQSpEEQQQTEDELQD47 
29KIEKFQSpEEQQQTEDELQDKIHP51 
29KIEKFQSpEEQQQTEDELQDKIHPF52 
29KIEKFQSpEEQQQTEDELQDKIHPFAQTQ56 
30IEKFQSpEEQQQTEDELQDKIHPF52 
32KFQSpEEQQ39 
32KFQSpEEQQQ40 
32KFQSpEEQQQTE42 
32KFQSpEEQQQTED43 
32KFQSpEEQQQTEDELQ46 
32KFQSpEEQQQTEDELQD47 
32KFQSpEEQQQTEDELQDKIHPF52 
32KFQSpEEQQQTEDELQDKIHPFAQTQ56 
33FQSpEEQQQTED43 
Ragusano-4 
month old  
WSFa 41SKDIGSpESpTEDQ52 
41SKDIGSpESpTEDQAM54 
41SKDIGSpESpTEDQAMED56 
75SpVEQKHIQ82 
75SpVEQKHIQKE84 
 1REL….IVESpLSpSpSpE…SpEEQQQTEDELQ46 
11EIVESpLSpSpSpEESITRINK28 
12IVESpLSpSpSpEESITRINK28 
15ISpLSpSpSpEESITRINK28 
17SpSpSpEESITRINK28 
29KIEKFQSpEEQQQTEDELQDKIHPF52 
29KIEKFQSpEEQQQTEDELQDKIHPFAQTQ56 
32KFQSpEEQQQ40 
32KFQSpEEQQQTED43 
32KFQSpEEQQQTEDELQDKIHPF52 
Gagnaire et 
al., 2011 
Ragusano-7 
month old  
WSFa 41SKDIGSpESpTEDQAM54 
41SKDIGSpESpTEDQAMED56 
42KDIGSpESpTEDQAMED56 
75SpVEQKHIQ82 
126EQLSpTSEENSpKKT138 11EIVESpLSpSpSpEESITRINK28 
12IVESpLSpSpSpEESITRINK28 
17SpSpSpEESITRINK28 
29KIEKFQSpEEQQQTEDELQDKIHPF52 
Gagnaire et 
al., 2011 
a Water soluble extract; Sp: Ser phosphorylated 
b Dupas, C., Adt, I., Cottaz, A., Boutrou, R., Molle, D., Jardin, J., Jouvet, T., Degraeve, P., 2009. A chromatographic procedure for semi-quantitative evaluation of 
caseinphosphopeptides in cheese. Dairy Science Technology 89, 519-529. 
c Gagnaire, V., Molle, D., Herrouin, M., Leonil, J. 2001. Peptides identified during Emmental cheese ripening: Origin and proteolytic systems involved. Journal of 
Agricultural and Food Chemistry 49, 4402-4413. 
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d Lund, M., Ardö, Y., 2004. Purification and identification of water soluble phosphopeptides from cheese using Fe(III) affinity chromatography and mass spectrometry. 
Journal of Agricultural and Food Chemistry 52, 6616-6622. 
 
 
 
